Chronic buprenorphine-associated severe central sleep apnea and desaturation proof of concept
Sleep Medicine · 2027-01 · 149 · 109347
DOI: 10.1016/j.sleep.2026.109347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep Medicine, 2027-01. Verfasst von S Javaheri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Sleep Medicine, Bethesda North Hospital, Cincinnati, OH, USA; Division of Cardiology, The Ohio State University, Columbus, …. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Individuals on opioids are found dead in bed and respiratory depression is a potential cause. In contrast to other opioids, buprenorphine, a partial μ-opioid receptor agonist has reduced respiratory depression. However, death has also been reported in individuals using buprenorphine; yet, it is not known if chronic use of buprenorphine could be associated with clinically significant respiratory depression. OBJECTIVE: The purpose of this preliminary study was to determine if chronic buprenorphine use is associated with sleep disordered breathing. METHODS: A retrospective study of 11 consecutive patients who were using buprenorphine chronically and referred for sleep evaluation. All underwent full night attended polysomnography and polysomnograms were scored page by page by a board-certified sleep physician. RESULTS: Two breathing patterns were observed. First, four patients had central sleep apnea (CSA) with an index of ≥5/h of sleep and an average of 13. When compared to those without CSA, patients with CSA suffered from severe sleep apnea with an apnea hypopnea index (AHI) of 35 (vs.9/hour of sleep) and associated with clinically significant low saturation (75% vs. 87%). Second, the group without significant CSA (CAI
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary and Sleep Medicine, Bethesda North Hospital, Cincinnati, OH, USA; Division of Cardiology, The Ohio State University, Columbus, OH, USA; Division of Pulmonary and Sleep Medicine, University of Cinci…
- Trihealth Hospitals, USA.
Zitieren
APA
Javaheri, S., Eshgabaidi, A., Aboelnasr, A., & Forgo, V. (2027). Chronic buprenorphine-associated severe central sleep apnea and desaturation proof of concept. Sleep Medicine, 149, 109347. https://doi.org/10.1016/j.sleep.2026.109347
Vancouver
Javaheri S, Eshgabaidi A, Aboelnasr A, Forgo V. Chronic buprenorphine-associated severe central sleep apnea and desaturation proof of concept. Sleep Medicine. 2027;149:109347. doi:10.1016/j.sleep.2026.109347
BibTeX
@article{Javaheri2027,
author = {Javaheri, S and Eshgabaidi, A and Aboelnasr, A and Forgo, V},
title = {Chronic buprenorphine-associated severe central sleep apnea and desaturation proof of concept},
journal = {Sleep Medicine},
year = {2027},
volume = {149},
pages = {109347},
doi = {10.1016/j.sleep.2026.109347}
}
EUVIMED